Catheter Precision, Inc. Files 8-K on Financials
Ticker: VTAK · Form: 8-K · Filed: Aug 15, 2024 · CIK: 1716621
| Field | Detail |
|---|---|
| Company | Catheter Precision, Inc. (VTAK) |
| Form Type | 8-K |
| Filed Date | Aug 15, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-K, company-name-change
Related Tickers: CATX
TL;DR
CATX filed an 8-K detailing financial results and exhibits; formerly Ra Medical Systems.
AI Summary
Catheter Precision, Inc. filed an 8-K on August 14, 2024, reporting on its results of operations and financial condition. The filing also includes financial statements and exhibits. The company was formerly known as Ra Medical Systems, Inc. and changed its name on September 8, 2017.
Why It Matters
This 8-K filing provides investors with crucial updates on Catheter Precision, Inc.'s financial performance and operational status. It is essential for understanding the company's current health and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not indicate any immediate or significant risks.
Key Players & Entities
- Catheter Precision, Inc. (company) — Registrant
- Ra Medical Systems, Inc. (company) — Former company name
- August 14, 2024 (date) — Date of earliest event reported
- September 8, 2017 (date) — Date of name change
FAQ
What is the primary purpose of this 8-K filing for Catheter Precision, Inc.?
The primary purpose is to report on the company's Results of Operations and Financial Condition, as well as to include Financial Statements and Exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on August 14, 2024.
What was Catheter Precision, Inc.'s former name?
Catheter Precision, Inc.'s former name was Ra Medical Systems, Inc.
On what date did the company change its name from Ra Medical Systems, Inc.?
The company changed its name on September 8, 2017.
What is the Standard Industrial Classification code for Catheter Precision, Inc.?
The Standard Industrial Classification code for Catheter Precision, Inc. is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
Filing Stats: 554 words · 2 min read · ~2 pages · Grade level 11.2 · Accepted 2024-08-15 16:16:21
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share VTAK NYSE American Indic
Filing Documents
- vtak_8k.htm (8-K) — 25KB
- vtak_ex991.htm (EX-99.1) — 17KB
- vtak_ex991img1.jpg (GRAPHIC) — 4KB
- 0001654954-24-010758.txt ( ) — 174KB
- vtak-20240814.xsd (EX-101.SCH) — 6KB
- vtak-20240814_lab.xml (EX-101.LAB) — 14KB
- vtak-20240814_cal.xml (EX-101.CAL) — 1KB
- vtak-20240814_pre.xml (EX-101.PRE) — 9KB
- vtak-20240814_def.xml (EX-101.DEF) — 2KB
- vtak_8k_htm.xml (XML) — 4KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On August 14, 2024, Catheter Precision, Inc. (the "Company") issued a press release announcing its financial results for the quarter ended June 30, 2024. The full text of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information in this Item 2.02, Exhibit 99.1 attached hereto, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this current report shall not be incorporated by reference into any registration statement or other document filed with the Securities and Exchange Commission, whether filed before or after the date hereof regardless of any general incorporation language in any such filing, unless the registrant expressly sets forth in such filing that such information is to be considered "filed" or incorporated by reference therein.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit Description 99.1 Press Release Issued on August 14, 2024 104 Cover Page Interactive Data File (formatted as inline XBRL) 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CATHETER PRECISION, INC. Date: August 15, 2024 By: /s/ Margrit Thomassen Margrit Thomassen Interim Chief Financial Officer 3